BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2449 related articles for article (PubMed ID: 20195006)

  • 1. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of HIV and psychotropic medications among persons with serious mental illness and HIV/AIDS.
    Lee S; Rothbard AB; Noll E; Blank MB
    Adm Policy Ment Health; 2011 Sep; 38(5):335-44. PubMed ID: 20976619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS.
    Rothbard AB; Metraux S; Blank MB
    Psychiatr Serv; 2003 Sep; 54(9):1240-6. PubMed ID: 12954940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
    Stoll M; Claes C; Schulte E; Graf von der Schulenburg JM; Schmidt RE
    Eur J Med Res; 2002 Nov; 7(11):463-71. PubMed ID: 12568973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pursuing cost-effectiveness in mental health service delivery for youth with complex needs.
    Grimes KE; Schulz MF; Cohen SA; Mullin BO; Lehar SE; Tien S
    J Ment Health Policy Econ; 2011 Jun; 14(2):73-83. PubMed ID: 21881163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.
    Bozzette SA; Joyce G; McCaffrey DF; Leibowitz AA; Morton SC; Berry SH; Rastegar A; Timberlake D; Shapiro MF; Goldman DP;
    N Engl J Med; 2001 Mar; 344(11):817-23. PubMed ID: 11248159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.
    Kaskie B; Wallace N; Kang S; Bloom J
    J Ment Health Policy Econ; 2006 Mar; 9(1):15-24. PubMed ID: 16733268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of care for people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders.
    Conover CJ; Weaver M; Ang A; Arno P; Flynn PM; Ettner SL;
    AIDS Care; 2009 Dec; 21(12):1547-59. PubMed ID: 20024734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid managed care and the distribution of societal costs for persons with severe mental illness.
    Shern DL; Jones K; Chen HJ; Jordan N; Ramoni-Perazzi J; Boothroyd RA
    Am J Psychiatry; 2008 Feb; 165(2):254-60. PubMed ID: 18198269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the effects of organization and financing on the utilization and costs of public mental health services in san diego county.
    Gilmer T
    J Ment Health Policy Econ; 2007 Sep; 10(3):123-32. PubMed ID: 17890829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does Cash and Counseling affect costs?
    Dale SB; Brown RS
    Health Serv Res; 2007 Feb; 42(1 Pt 2):488-509. PubMed ID: 17244294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial Burden and Out-of-Pocket Expenditures for Mental Health Across Different Socioeconomic Groups: Results from HealthCare for Communities.
    Ringel JS; Sturm R
    J Ment Health Policy Econ; 2001 Sep; 4(3):141-150. PubMed ID: 11967474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do reduced inpatient costs associated with highly active antiretroviral therapy (HAART) balance the overall cost for HIV treatment?
    Farnham PG
    Appl Health Econ Health Policy; 2010; 8(2):75-88. PubMed ID: 20175587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An expenditure analysis of high-cost Medicaid recipients with HIV disease in New York State.
    Chesnut TJ; Laufer FN; Carrascal AF; Feldman IS
    J Health Care Poor Underserved; 2011 Feb; 22(1):330-45. PubMed ID: 21317526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 123.